These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tufted-angioma-like lesion associated with vascular endothelial growth factor and interleukin-6 in TAFRO syndrome: Is it a common histological feature of multicentric Castleman disease/POEMS syndrome? Fujita K; Hatta K J Cutan Pathol; 2019 Apr; 46(4):280-284. PubMed ID: 30632181 [TBL] [Abstract][Full Text] [Related]
3. Castleman disease and TAFRO syndrome. Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513 [TBL] [Abstract][Full Text] [Related]
4. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease. Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567 [TBL] [Abstract][Full Text] [Related]
5. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819 [TBL] [Abstract][Full Text] [Related]
10. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome. Iwaki N; Gion Y; Kondo E; Kawano M; Masunari T; Moro H; Nikkuni K; Takai K; Hagihara M; Hashimoto Y; Yokota K; Okamoto M; Nakao S; Yoshino T; Sato Y Sci Rep; 2017 Feb; 7():42316. PubMed ID: 28205564 [TBL] [Abstract][Full Text] [Related]
11. Glomeruloid hemangioma associated with TAFRO syndrome. Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119 [TBL] [Abstract][Full Text] [Related]
12. Case report: Castleman disease in association with POEMS. Adelman HM; Cacciatore ML; Pascual JF; Mike JM; Alberts WM; Wallach PM Am J Med Sci; 1994 Feb; 307(2):112-4. PubMed ID: 8141136 [TBL] [Abstract][Full Text] [Related]
13. Subclinical Hypothyroidism in TAFRO Syndrome. Oka S; Ono K; Nohgawa M Intern Med; 2019 Sep; 58(18):2615-2620. PubMed ID: 31178506 [TBL] [Abstract][Full Text] [Related]
14. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities. Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103 [TBL] [Abstract][Full Text] [Related]
15. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. D'Souza A; Hayman SR; Buadi F; Mauermann M; Lacy MQ; Gertz MA; Kyle RA; Kumar S; Greipp PR; Lust JA; Russell SJ; Zeldenrust S; Dingli D; Witzig TE; Rajkumar SV; Dispenzieri A Blood; 2011 Oct; 118(17):4663-5. PubMed ID: 21881050 [TBL] [Abstract][Full Text] [Related]
16. Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report. Ge Y; Da Q; Dai Y BMC Neurol; 2018 Oct; 18(1):169. PubMed ID: 30301456 [TBL] [Abstract][Full Text] [Related]
17. [Incomplete POEMS syndrome with multicentric Castleman's disease]. González de la Aleja P; García-Navarro M; Sánchez-Martínez R; Ramos JM An Sist Sanit Navar; 2017 Dec; 40(3):475-478. PubMed ID: 28906499 [TBL] [Abstract][Full Text] [Related]